NFKB1 and colorectal carcinoma: Moreover, it was found that there was no significant difference between co-treatment of resveratrol (5 μM) and NF-κB-SO (0.5 μM) or resveratrol (5 μM) alone on reduced inhibition of migration and invasion and their size on CRC cells (Figures 4A,B, Figures 5A,B,D,E).